BC Week In Review | Aug 22, 2011
Clinical News

Propel mometasone furoate implant regulatory update

FDA approved a PMA from Intersect for Propel mometasone furoate implant to treat chronic sinusitis. Intersect plans to launch the bioabsorbable, steroid-eluting implant this fall. Intersect ENT Inc. , Palo Alto, Calif.   Product: Propel mometasone...
Items per page:
1 - 1 of 1